HK Stock Market Move | |Hisense Home Appliances Group (00921) rises over 5%; raw material prices have fallen significantly recently, and cost-side pressure on home appliance makers is expected to ease.
Hisense Home Appliances Group (00921) rose over 5%. As of press time, it was up 4.93% at HK$19.15, with a turnover of HK$31.4662 million.
Hisense Home Appliances Group (00921) rose over 5%, up 4.93% as of press time at HK$19.15, with turnover of HK$31.4662 million.
On the news front, prices of raw materials such as copper and aluminum have continued to decline recently, and the market expects profitability of home appliance companies to improve. As of November 17, London copper, London aluminum, and Brent crude prices had fallen about 11%, 12%, and 22%, respectively, from their recent three-month highs. Guotai Haitong previously noted that the company's gross margin decline in the third quarter dragged on earnings performance, estimated mainly due to larger declines in residential air conditioners and central air conditioners amid rising raw material costs and intensifying competition.
BofA Securities also previously said that Hisense Home Appliances Group, due to thinner profit margins and greater central air conditioner exposure, is more vulnerable than peers to the property market cycle and cost inflation, but the relevant risks have been reflected in its valuation, equivalent to 7x 2027 forecast price-to-earnings ratio and a 7% dividend yield.
Related Articles

HK Stock Market Move | CSTONE PHARMA-B (02616) rose over 11% in the afternoon; the company plans to initiate the global Phase III registrational clinical trial of CS2009 by the end of 2026.

No Human Intervention Needed! JPMorgan (JPM.US) Teams Up with Hyundai Card to Explore Autonomous Financial Transactions by AI Agents

HAITONG INT'L: Cuts Eastroc Beverage (09980) target price to HK$123, maintains "Outperform" rating
HK Stock Market Move | CSTONE PHARMA-B (02616) rose over 11% in the afternoon; the company plans to initiate the global Phase III registrational clinical trial of CS2009 by the end of 2026.

No Human Intervention Needed! JPMorgan (JPM.US) Teams Up with Hyundai Card to Explore Autonomous Financial Transactions by AI Agents

HAITONG INT'L: Cuts Eastroc Beverage (09980) target price to HK$123, maintains "Outperform" rating






